Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|13|10|2009-2021
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.10, 2012-08, pp. : 2009-2021
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :
Access to resources
Recommend
Epigenetics and Sjogren's Syndrome
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :
Sjogren’s syndrome: evolving therapies
By Fox Robert I
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. :
Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :
Autoantibodies and Sjogren's Syndrome: A Physiologist's Perspective
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :